ABSTRACT
The pandemic of coronavirus disease 2019 (COVID-19) started in Wuhan, China, and spread worldwide. In India, COVID-19 cases increased rapidly throughout India. Various measures like awareness program, social distancing, and contact tracing have been implemented to control the COVID-19 outbreak. In the absence of any vaccine, the prediction of the confirmed, deceased, and recovered cases is required to enhance the health care system’s capacity and control the transmission. In this study, the cumulative and daily confirmed, deceased, and recovered cases in Uttar Pradesh, India, were analyzed. We used the logistic and Gompertz non-linear regression model using a Bayesian paradigm. We build the prior distribution of the model using information obtained from some other states of India, which are already reached at the advanced stage of COVID-19. Results from the analysis indicated that the predicted maximum number of confirmed, deceased, and recovered cases will be around 1157335, 5843, and 1145829 respectively. The daily number of confirmed, deceased, and recovered cases will be maximum at 104th day, 73rd day, and 124th day from 16 June 2020. Further from this analysis we can conclude that the COVID-19 will be over probably by early-June, 2021. The analysis did not consider any changes in government control measures. We hope this study can provide some relevant information to the government and health officials.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos